<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | McIntyre Ebsen | Activity</title>
	<link>https://recash.wpsoul.net/members/frameant8/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/frameant8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for McIntyre Ebsen.</description>
	<lastBuildDate>Thu, 21 May 2026 03:32:18 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">6420975e4a2a2878fccaa0abc667f6c7</guid>
				<title>McIntyre Ebsen posted an update: 7% (44/66) and 42.9% (15/35) were in remission. At M6 [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/49397/</link>
				<pubDate>Wed, 11 Dec 2024 11:27:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>7% (44/66) and 42.9% (15/35) were in remission. At M6 remission rates was significantly higher while response rates tended to be higher among biologic-naïve versus biologic-failure CD patients. Conclusions VDZ offers an effective treatment option in real-life settings and treatment effectiveness appears higher in biologic-naïve versus b&hellip;<span class="activity-read-more" id="activity-read-more-49397"><a href="https://recash.wpsoul.net/activity/p/49397/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e2d9d93bb49aebbccf5e1ece94735a91</guid>
				<title>McIntyre Ebsen became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/49263/</link>
				<pubDate>Wed, 11 Dec 2024 11:09:09 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>